IHI is an EU public-private partnership funding collaborative health research & innovation under Horizon Europe, to improve lives and advance healthcare.

The Innovative Health Initiative JU helps deliver an innovative, more integrated approach to health research and healthcare in the EU. Find out more.

IHI has a total budget of €2.4 billion and is funded jointly by the EU and by industry associations representing Europe’s life science industries. https://european-union.europa.eu/institutions-law-budget/institutions-and-bo...

To maximise the efficiency of the calls management, IHI JU will continuously explore and implement simplifications and improve its processes while maintaining the highest standards of the evaluation process, in line with the applicable Horizon Europe rules.

Eligibility for IHI JU funding mainly depends on the place of establishment and the legal status of a legal entity, but it also depends on the type of IHI JU call and some IHI JU specificities, which are addressed in this section.

The Innovative Health Initiative Joint Undertaking (IHI JU) is a public-private partnership between the European Union, represented by the European Commission, and several health industries from the biopharmaceutical, biotechnology and medical technology sectors.

The Innovative Health Initiative Joint Undertaking (IHI JU) is a partnership for health research and innovation between the EU and Europe’s life science industries.

The Innovative Health Initiative Joint Undertaking (IHI JU) is a European initiative to improve the competitive situation of the European Union in the field of pharmaceutical research.

The proposed IHI JU topic would strengthen collaboration between healthcare system stakeholders to reduce emissions of, and exposure to PFAS, evaluate alternatives and therefore, contribute to the EU Chemicals Strategy for Sustainability of the EU Green Deal.

The Innovative Health Initiative Joint Undertaking (IHI JU) has now completed the evaluation of the proposals submitted to the above-mentioned call. ‘quality and efficiency of the implementation’. The individual threshold for each criterion is 3 and the overall threshold is 10. The first ranked ... The results of the evaluation are as follows: